The expression of exosomal-annexin A2 was found significantly higher in sera of breast cancer patients compared to non-cancer subjects, particularly in African-American women with Triple-Negative Breast Cancer (TNBC), and was shown to be associated with poorer clinic-pathological features of the breast cancer patients. This evidence concerns the gene ANXA2 and breast carcinoma.